News & Events




October 05, 2018

MediSprout, a leader in the development of innovative healthcare and telehealth solutions, this week announced that its simple-to-implement V2MD telehealth platform will now integrate with Amazon Alexa for patient scheduling and integration with its Withings Wireless Blood Pressure Monitor. 

Retia Medical Establishes World-Class Clinical Advisory Board to Support Critical Advances in Hemodynamic Monitoring

October 10, 2018

Valhalla, NY – October 10, 2018 – Retia Medical, LLC, a medical device company focused on transforming the practice of critical care by making accurate hemodynamic data available and affordable for use at every bed, today announced that it established a Clinical Advisory Board comprising experts in the fields of anesthesiology and critical care medicine. The Clinical Advisory Board will provide insights into the design of clinical trials for the company’s lead product, the Retia Argos Cardiac Output Monitor, development of additional algorithms to improve hemodynamic monitoring, and support peer-to-peer educational initiatives that increase patient access to potentially life-saving hemodynamic monitoring technologies. The company also announced that it will preview the Argos Monitor at ANESTHESIOLOGY® 2018, the annual meeting of the American Society of Anesthesiology, which is taking place in San Francisco, October 13 -17


September 13, 2018

Valhalla, N.Y. – September 12, 2018New York Medical College (NYMC) announced that Affina Biotechnologies  is the latest client to join BioInc@NYMC, NYMC’s biotechnology incubator — a New York State-designated Innovation Hot Spot. Affina Biotechnologies is a drug discovery start up that also offers services in protein biochemistry and assay development. There are currently nine start-ups occupying BioInc@NYMC, the mid-Hudson Valley’s only fully-equipped incubator on a health sciences college campus.

MediSprout app offers timely care without waiting room angst

August 05, 2018

In 2014, Samant Virk was more than a decade into a career in private practice as a neurologist in Poughkeepsie, but he couldn’t shake the feeling that something

Sapience Therapeutics, Inc. Selected as a Winner of the JLABS NYC QuickFire Challenge

June 26, 2018

HARRISON, N.Y., June 26, 2018 (GLOBE NEWSWIRE) -- Sapience Therapeutics, Inc., a biotechnology company focused on developing peptide therapeutics to address difficult to treat oncology indications, announced today that it was selected by Johnson & Johnson Innovation, JLABS (JLABS) as a winner of the JLABS @ NYC QuickFire challenge. Sapience was awarded one year of residency at the JLABS @ NYC, which includes laboratory space and access to Johnson & Johnson Innovation’s network of experts.

BioInc@NYMC and iCANny Host “Their Big Idea” Event

July 06, 2018

“This event is a part of our mission to foster entrepreneurship and economic growth in New York State,” said Deborah Novick, director of BioInc@NYMC.

TruMada Initiative Hosts Entrepreneurs And Prospective Investors For "Shark Tank" Inspired Event

February 08, 2018

We are seeing tremendous medical innovation come out of Israel, but many of these companies lack the knowledge and experience to successfully expand in the U.S.

President of Guatemala Visited NYMC To Explore Possible Collaborations

February 13, 2018

Inspired by the NYMC’s innovation around biotechnology and state-of-the-art medical equipment, President Morales plans to take key learning points back to people of Guatemala.

BioInc@NYMC Client Crave Crush Now Available Nationwide

August 17, 2017

Crave Crush helps individuals lead healthier lives by eating less sugar. The main ingredient in its patented lozenge is gymnema, a natural leaf extract that supports healthy dietary habits. 

BioInc@NYMC Names New Director

January 11, 2018

BioInc@NYMC has established itself as the premier biomedical incubator in the region and I am eager to join and help support its mission and the success of its members

New York Medical College Welcomes Two New BioInc Tenants

November 10, 2015

SHY Therapeutics and MediSprout Join NYMC’S Innovative Biotech Incubator

BioInc@NYMC Welcomes Sapience Therapeutics, Inc.

August 03, 2016

Sapience Therapeutics, Inc. Developing Therapeutic Agent to Address High Mortality Cancers

NYMC Biotechnology Incubator Receives More Than One Million Dollars in State Funding To Support Innovation Hot Spot

December 22, 2017

BioInc@NYMC has seen phenomenal growth and success in its short three-year history

NYMC Welcomes New BioInc Client

April 15, 2015

Four LLC to Become Fourth Member of the College’s Innovative Biotech Incubator

New York Medical College Announces First Incubator Tenants

January 15, 2015

BioInc@NYMC is the only incubator of its kind in the region that is located on a medical school campus 

New York Medical College Biotech Incubator Receives Innovation Spot Award

December 12, 2014

BioInc@NYMC funded to help improve New York’s competitiveness in growing new technology based companies 

New York Medical College Launches Transformative Biotechnology Incubator

October 29, 2014

BioInc@NYMC is a vibrant, intellectually supportive platform for innovation and development that encourages collaboration and synergistic relationships among entrepreneurs.